Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Living an active lifestyle reduces chances of dying immediately after a heart attack

The study, published in the European Journal of Preventive Cardiology, included data from more than 28,000 patients. 

Thumbnail

FDA approves expanded indication for sacubitril/valsartan

Manufactured by Novartis under the name Entresto, the medication is now also approved for treating HFpEF. 

Thumbnail

Healthcare for children heavily delayed during the pandemic

A significant proportion of parents delayed or put off healthcare visits and care for their children during the Covid-19 pandemic, according to a new report from the Urban Institute and the Robert Wood Johnson Foundation.

 

coronavirus COVID-19 vaccine vaccination

AI algorithm targets new coronavirus outbreaks

Researchers are using AI to predict which mammals are hosts of new coronavirus diseases, potentially identifying and predicting new outbreaks before they become deadly in the future.

 

Heart failure medication may offer relief for patients with COVID-related POTS

Overall, researchers found that ivabradine was a “safe and effective” POTS treatment associated with making significant improvements to patient heart rates and quality of life.

chest pain lung pulmonary embolism

AI spots dozens of missed incidental pulmonary embolism diagnoses at one hospital

The investigation was retrospective, but Duke scientists believe their algorithm could potentially aid radiologists in spotting near-misses in their work.

American College of Cardiology calls for high-risk heart disease patients to be prioritized for COVID-19 vaccination

According to the new recommendation, patients with advanced cardiovascular disease are at an especially high risk of COVID-related complications and need to be vaccinated as quickly as possible. 

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.